Phibro Animal Health Corporation (NASDAQ:PAHC) Announces Quarterly Dividend of $0.12

Phibro Animal Health Corporation (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, July 28th. Stockholders of record on Wednesday, September 2nd will be given a dividend of 0.12 per share on Wednesday, September 23rd. This represents a c) annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, September 2nd.

Phibro Animal Health has a payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Phibro Animal Health to earn $3.33 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 14.4%.

Phibro Animal Health Trading Up 0.8%

Shares of Phibro Animal Health stock traded up $0.28 during trading on Wednesday, reaching $36.65. 4,841 shares of the company were exchanged, compared to its average volume of 309,551. The business has a 50-day moving average price of $32.52 and a 200-day moving average price of $43.24. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 15.72, a P/E/G ratio of 0.49 and a beta of 0.46. The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97. Phibro Animal Health has a twelve month low of $25.58 and a twelve month high of $60.08.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, May 6th. The company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.04. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. The company had revenue of $383.54 million for the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. Sell-side analysts anticipate that Phibro Animal Health will post 3.08 EPS for the current fiscal year.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.